Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivostat PRF in non-ischemic diabetic foot ulcers (feasibility study)
2009-011755-47Phase 2Completed
- Sponsor
- Vivostat
- Start
- Apr 2009
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Vivostat in diabetic foot ulcer (DFU), sponsored by Vivostat. Primary endpoint: Complete ulcer healing at 12 weeks. Started Apr 2009; status: completed.
02
Drugs
Vivostat
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2009-011755-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011755-47.